hemp – Page 10 – cannabis.co.nz

November 3, 202019, 2020, 2021, 280E, acquisition, analysis, analytics, annual, appellations, beverages, business, Business Analysis, CA, calcannabis, Cali, california, cannabinoid, cannabis, cbd, competition, compliance, consolidation, consumer, Coronavirus, COVID, COVID-19, cultivate, cultivating, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, distribution, distributor, equity, Federal, finance, financial, forecast, formalize, government, growing, hemp, industry, jurisdiction, lab, law, legal, legalization, legalize, legislation, license, Licesning, liquidity, marginalized, marijuana, market, medical, medicine, merger, New, niche, opportunities, pandemic, price, product, Product Development, products, project, Quality, quarantine, recreational, regulation, regulatory, restrictions, retail, services, social, spending, state, Sustainability, tax, thc, turmoil, year

2021 Trends: Nine Developments in California’s Cannabis Market

While we’re pleased to report that 2020 is almost over, 2021 will be a mixed bag. New jurisdictions will open their doors […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

October 27, 2020analysis, analytics, audit, branding, business, Business Analysis, cannabidiol, cannabis, cbd, certificate, certification, chain, COA, compliance, Concentrates & Extracts, contract, credibility, cultivation, demographic, derived, differentiate, Dispensaries & Retail, Edibles & Processing, extraction, Federal, GFSI, Global Food Safety Initiative, government, growing, hemp, industry, label, labeling, labelling, law, legal, legalization, legalize, legislation, license, manufacturing, marijuana, market, marketing, organic, party, private, product, Product Development, program, Quality, recreational, regulation, regulatory, retail, Safe Quality Food, safety, seal, SQF, state, supply, test, third, third-party, transparency, USDA, white

Overcoming Challenges in the Private Label CBD Industry

Private labelling, or white labelling, is a popular option for brands looking to enter the CBD space. This practice is where a […]

October 23, 20200.3, 2018, affairs, Agricultural Improvement Act, analysis, analytics, ban, bill, business, Business Analysis, california, cannabidiol, cannabis, cbd, committee, compliance, consumer, court, cultivation, derived, enact, extraction, farm, farm bill, Federal, florida, Georgia, government, growing, Hawaii, hemp, hemp-derived, house, illinois, Indiana, Iowa, kansas, law, Laws, lawsuit, legal, legality, legalization, legislation, license, Louisiana, marijuana, market, massachusetts, michigan, mississippi, new jersey, new york, of appeals, producer, product, Quality, regulating, regulation, regulations, regulatory, retail, safety, senate, state, test, Testing, Texas, thc, Utah, washington

A Survey of State CBD & Hemp Regulation Since The 2018 Farm Bill

Since the December 20, 2018 enactment of the Agricultural Improvement Act of 2018, better known as the Farm Bill, we have seen […]

October 22, 2020%, 0.3, 2018, analysis, authority, business, cannabidiol, cannabis, cbd, compliance, dea, extraction, farm bill, Federal, government, growing, hemp, industry, interim, jurisdiction, law, legal, legalization, legalize, legislation, license, marijuana, market, national cannabis industry association, NCIA, product, regulation, regulations, regulatory, rule, rulemaking, state, thc, threshold, USDA

NCIA to DEA: Rescind the Interim Hemp Rule

In a press release published this week, the National Cannabis Industry Association (NCIA) urges the DEA to rescind the controversial Interim Hemp […]

September 30, 202017025, 2019, accreditation, analysis, analytics, business, california, cannabis, CannaSafe, cbd, CDC, compliance, crisis, EVALI, expansion, government, growing, Health, hemp, IEC, industry, ISO, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, Perry Johnson Laboratory Accreditation, PJLA, product, Quality, RC - Cannabis Analysis, recreational, regulation, regulations, regulatory, safe, safety, state, test, Testing, thc, Van Nuys, vape, vaping, vitamin e acetate

CannaSafe Accredited to ISO 17025

According to a press release sent out last week, Perry Johnson Laboratory Accreditation, Inc. announced the accreditation of CannaSafe Labs to ISO/IEC […]

September 29, 20202017, A2LA, accredit, accreditation, American Association for Laboratory Accreditation, analysis, analytics, business, cannabis, cbd, compliance, consumer, dea, Federal, government, growing, hemp, IEC, industry, ISO, ISO 17025, lab, laboratories, Laboratories & Analytics, laboratory, labs, legalization, legalize, legislation, license, marijuana, market, Mount Laurel, new jersey, product, Quality, RC - Cannabis & Hemp Testing Solutions, regulation, regulations, regulatory, safety, state, test, Testing, Trichome Analytical

Trichome Analytical Accredited to ISO 17025

According to a press release sent out last week, the American Association for Laboratory Accreditation (A2LA) announced the accreditation of Trichome Analytical […]

September 24, 2020%, 0.3, 2018, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Concentrates & Extracts, consumer, controlled, cultivation, dea, derived, Drug Enforcement Administration, Edibles & Processing, extraction, farm bill, Federal, final, government, growing, hemp, industry, interim, justice department, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, limit, marihuana, marijuana, market, product, Product Development, Quality, regulation, regulations, regulatory, rule, rulemaking, schedule, state, substance, test, Testing, thc

The DEA’s Interim Final Rule and its Impact on the Industrial Hemp Industry

On August 20, 2020, the Drug Enforcement Administration (DEA) published an Interim Final Rule on industrial hemp and hemp derivatives (the interim […]

September 10, 2020analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Congress, congressional, controlled substances act, cultivation, dea, department of justice, derived, DOJ, Drug Enforcement Administration, farm, Farming, FDA, FDCA, Federal, food and drug administration, government, growing, hemp, industry, interim, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, National Institute of Standards and Technology, NIST, plant, plants, political, politics, product, Quality, recreational, reg, regulation, regulations, regulatory, retail, rule, safety, schedule, state, test, Testing, thc, THCA

CBD Industry Caught Between Regulators & Law Enforcement

The consumer-facing CBD industry operates in a regulatory gray zone even as it grows in prominence. Illegal to market as an unapproved […]

September 4, 202022, analysis, analytics, beverage, business, Business Analysis, Canalysis, cannabidiol, cannabis, cbd, compliance, consumer, Dispensaries & Retail, drink, Edibles & Processing, government, growing, hemp, independent, industry, infused, lab, laboratories, laboratory, labs, law, Leafreport, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Product Development, products, Quality, regulation, regulations, regulatory, reputation, safety, state, test, tested, Testing, thc, watchdog

CBD Watchdog Finds Beverage Labeling Inaccuracies

According to a press release published in late August, CBD watchdog Leafreport found a large number of inaccuracies when testing CBD-infused beverages […]